AU1884395A - Antithrombotic agents - Google Patents

Antithrombotic agents

Info

Publication number
AU1884395A
AU1884395A AU18843/95A AU1884395A AU1884395A AU 1884395 A AU1884395 A AU 1884395A AU 18843/95 A AU18843/95 A AU 18843/95A AU 1884395 A AU1884395 A AU 1884395A AU 1884395 A AU1884395 A AU 1884395A
Authority
AU
Australia
Prior art keywords
antithrombotic agents
antithrombotic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18843/95A
Other languages
English (en)
Inventor
Aaron Leigh Schacht
Robert Theodore Shuman
Gerald Floyd Smith
James Howard Wikel
Michael Robert Wiley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/318,600 external-priority patent/US5602101A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1884395A publication Critical patent/AU1884395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU18843/95A 1994-03-04 1995-03-03 Antithrombotic agents Abandoned AU1884395A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20650094A 1994-03-04 1994-03-04
US206500 1994-03-04
US08/318,600 US5602101A (en) 1994-03-04 1994-10-05 Antithrombotic agents
US318600 1994-10-05
PCT/US1995/002627 WO1995023809A1 (fr) 1994-03-04 1995-03-03 Agents antithrombotiques

Publications (1)

Publication Number Publication Date
AU1884395A true AU1884395A (en) 1995-09-18

Family

ID=26901406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18843/95A Abandoned AU1884395A (en) 1994-03-04 1995-03-03 Antithrombotic agents

Country Status (5)

Country Link
EP (1) EP0748333A4 (fr)
JP (1) JPH09509943A (fr)
AU (1) AU1884395A (fr)
CA (1) CA2184188A1 (fr)
WO (1) WO1995023809A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990071666A (ko) * 1995-11-30 1999-09-27 이경하 술파미드 유도체
DE19549118C2 (de) * 1995-12-29 2000-07-13 Thomas W Stief Hämostaseaktivierungs-Inhibitor und Verfahren zum Hemmen der Hämostaseaktivierung in Blut oder anderen biologischen Flüssigkeiten
IL147696A0 (en) * 2001-01-25 2002-08-14 Pfizer Prod Inc Combination therapy
NZ531315A (en) * 2001-08-21 2005-08-26 Ivax Drug Res Inst Ltd Peptide arginals and methods for treating disseminated intravascular coagulation (DIC)
WO2004022549A1 (fr) * 2002-09-09 2004-03-18 Ono Pharmaceutical Co., Ltd. Procede de production d'halogenure de 4-methyl-1,3-thiazol-2-ylsulfonyle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
CA2075154A1 (fr) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Aldehydes peptidiques utilises comme agents antithrombotiques
ZA928581B (en) * 1991-11-12 1994-05-06 Lilly Co Eli Antithrombotic agents
US5250660A (en) * 1991-11-12 1993-10-05 Eli Lilly And Company Peptide purification process

Also Published As

Publication number Publication date
CA2184188A1 (fr) 1995-09-08
WO1995023809A1 (fr) 1995-09-08
EP0748333A4 (fr) 2000-05-10
EP0748333A1 (fr) 1996-12-18
JPH09509943A (ja) 1997-10-07

Similar Documents

Publication Publication Date Title
AU2263295A (en) Contrast agents
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4131596A (en) Polyglycomers
AU4044795A (en) Handleset
GB9504331D0 (en) Antithrombotic agents
AU1975195A (en) Antithrombotic agents
AU2308295A (en) Heterocyclylbenzonitriles
AU3554995A (en) Antipicornaviral agents
AU1963395A (en) Boom-structure
AU7170798A (en) Antithrombotic agents
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU1884395A (en) Antithrombotic agents
AU3166195A (en) Acylimidazopyridines
AU7274098A (en) Antithrombotic agents
AUPM365494A0 (en) Pre-chiller
AU3166095A (en) Benzylimidazopyridines
AU7170898A (en) Antithrombotic agents
ZA951615B (en) Antithrombotic agents
AU1603595A (en) Meso-azanoradamantanes
AU3446995A (en) Biodestumping
AU7563598A (en) Antithrombotic agents
AUPM938594A0 (en) Smokehood 173